<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0907245527
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2007
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        SODIUM CHLORIDE 0.225&+DEXTROSE5%I.V INF
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DEXTROSE,SODIUM CHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        5,0.225
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        %
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Intravenous infusion
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        500
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bag
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        60
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        4.1
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 540]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ZIMMO TRADING ESTABLISHMENT
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        B05BA03
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        B05CB01
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Sodium Chloride 0.225% w/v and Dextrose 5% w/v Intravenous Infusion B.P</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td><p><strong>Indications</strong></p></td></tr></tbody></table><p>&sect; Plasma-isotonic fluid substitution,</p><p>&sect; Substitution in hypochloraemic alkalosis,</p><p>&sect; Calorie supply,</p><p>&sect; Extra-cellular fluid depletion correction.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td><p><strong>Contraindications</strong></p></td></tr></tbody></table><p>&sect; Hypernatraemia,</p><p>&sect; Acidosis,</p><p>&sect; Hypokalaemia,</p><p>&sect; Diabetes mellitus</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td><p><strong>Precautions</strong></p></td></tr></tbody></table><p><strong>Do not use if leakage was found, solution is cloudy or contains particles.</strong></p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Intravenous infusion: </strong></p><p>3 ml/kg BW/hr. <u>i.e.</u> 70 drops/minute/70 kg BW <u>or</u> 210 ml/hr./70 kg BW</p><p>&nbsp;</p><p><strong>Maximum dosage: </strong></p><p>1500 ml/70 kg BW/day.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>NA</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Store below 25&deg; C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Each 100 ml contains:</strong></p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Dextrose Monohydrate</p></td><td style="vertical-align:top"><p>5.5 g</p></td></tr><tr><td style="vertical-align:top"><p>(Equiv. to Dextrose Anhydrous)</p></td><td style="vertical-align:top"><p>5.0 g</p></td></tr><tr><td style="vertical-align:top"><p>Sodium Chloride</p></td><td style="vertical-align:top"><p>0.225 g</p></td></tr><tr><td style="vertical-align:top"><p>Water for Injection</p></td><td style="vertical-align:top"><p>Q.S.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>Equiv. to 800 KJ (approx. (190) Kcal)/L</p></td></tr><tr><td style="vertical-align:top"><p>Na<sup>+</sup></p></td><td style="vertical-align:top"><p>38.5 mmol/L</p></td></tr><tr><td style="vertical-align:top"><p>Cl<sup>&macr;</sup></p></td><td style="vertical-align:top"><p>38.5 mmol/L</p></td></tr><tr><td style="vertical-align:top"><p>pH</p></td><td style="vertical-align:top"><p>3.5 &ndash; 6.5</p></td></tr><tr><td style="vertical-align:top"><p>Theor. Osmolarity</p></td><td style="vertical-align:top"><p>354 mOsm/L</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Hypertonic Solution for Intravenous Administration
Bottle size: 500 ml * 10 bottles.

Sterile, pyrogen free

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Kuwait Saudi Pharmaceutical Industries Company</p><p>Tel: +965 24745012/3/4</p><p>Fax: +965 24745361, P. O. Box: 5512, postal code: 13056 Safat, Kuwait</p><p>Website: <u>www.kspico.com</u></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                05/2010
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p><strong>صوديوم كلوريد ۰,۲۲٥٪ وزن/ حجم و دكستروز ٥٪ وزن/ حجم محلول حقن وريدي (ب.ف.)</strong></p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td><p dir="RTL"><strong>دواعي</strong><strong> </strong><strong>الاستعمال</strong></p></td></tr></tbody></table><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">&sect;&nbsp;&nbsp; تعويض السائل البلازمي،</p><p dir="RTL">&sect;&nbsp;&nbsp; التعويض في حالات نقص الكلوريد القلوي،</p><p dir="RTL">&sect;&nbsp;&nbsp; تصحيح النقص في السوائل خارج الخلايا،</p><p dir="RTL">&sect;&nbsp;&nbsp; يستعمل كمزود للطاقة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td><p dir="RTL"><strong>نواهي</strong><strong> </strong><strong>الاستعمال</strong></p></td></tr></tbody></table><p dir="RTL">&nbsp;</p><p dir="RTL">&sect;&nbsp;&nbsp; حالات ارتفاع الصوديوم في الدم،</p><p dir="RTL">&sect;&nbsp;&nbsp; حالات حموضة الدم،</p><p dir="RTL">&sect;&nbsp;&nbsp; حالات نقص البوتاسيوم في الدم،</p><p dir="RTL">&sect;&nbsp;&nbsp; مرض سكر الدم.</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td><p dir="RTL"><strong>الاحتياطات</strong></p></td></tr></tbody></table><p dir="RTL"><strong>لا تستعمله إن وجد تسريب، أو إذا كان المحلول معكر أو يحتوي على شوائب</strong><strong>.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>عن طريق الحقن الوريدي</strong><strong>: </strong></p><p dir="RTL">۳ مل/ كجم من وزن الجسم/ ساعة</p><p dir="RTL"><u>أي</u> ٧۰ نقطة/ دقيقة/ ٧۰ كجم من وزن الجسم <u>أو</u> ۲١۰ مل/ ساعة/ ٧۰ كجم من وزن الجسم.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>أقصى جرعة</strong><strong>:</strong></p><p dir="RTL">١,٥ &ndash; ۳,۰ جم دكستروز/ كجم من وزن الجسم/ يوم.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>غير متاح</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يحفظ في درجة حرارة أقل من ٢٥ درجة مئوية.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><u>يحتوي كل ١۰۰ مل من المحلول على</u><u>:</u></p><p dir="RTL">&nbsp;</p><table dir="rtl" border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL">دكستروز أحادي مائي</p></td><td style="vertical-align:top"><p dir="LTR">٥,٥ جم</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">(ما يعادل من الدكستروز اللا مائي)</p></td><td style="vertical-align:top"><p dir="LTR">٥,۰ جم</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">صوديوم كلوريد</p></td><td style="vertical-align:top"><p dir="LTR">۰,۲۲٥ جم</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">ماء للحقن</p></td><td style="vertical-align:top"><p dir="LTR">بقية المحلول</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">الطاقة (٨۰۰) كيلو جول (١٩۰ كيلو كالوري تقريبًا)/ لتر</p></td><td style="vertical-align:top"><p dir="LTR">&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">كاتيونات الصوديوم</p></td><td style="vertical-align:top"><p dir="LTR">۳٨,٥ ملي مول/ لتر</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">أنيونات الكلوريد</p></td><td style="vertical-align:top"><p dir="LTR">۳٨,٥ ملي مول/ لتر</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">الأس الهيدروجيني (معدل الحموضة)</p></td><td style="vertical-align:top"><p dir="LTR">۳,٥ &ndash; ٦,٥</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">الضغط الأسموزي الافتراضي</p></td><td style="vertical-align:top"><p dir="LTR">۳٥٤ ملي أوزم/ لتر</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">محلول للحقن الوريدي عالي الضغط الاسموزي</p><p dir="RTL">عبوة حجم: ٥۰۰ مل X ١۰ عبوات</p><p dir="RTL">معقم و خالي من الحميات.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong><u>الشركة المصنعة والمفوضة بالتسويق</u></strong></p><p dir="RTL"><strong>الشركة الكويتية السعودية للصناعات الدوائيه</strong></p><p dir="RTL">ص ب: 5512 ،الرمز البريدي: 13056 الصفاة، الكويت</p><p dir="RTL">هاتف: 96524745013-96524745014+</p><p dir="RTL">فاكس: 96524745361+</p><p dir="RTL">الموقع الالكتروني: www.kspico.com</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            05/2010
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Sodium Chloride 0.225% and Dextrose 5% Intravenous Infusion
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each 100 ml of Sodium Chloride 0.225% and Dextrose 5% I.V. Inusion contains:
Dextrose Monohydrate	5.5 g
Equiv. to Dextrose Anhydrous	5.0 g
Sodium Chloride	0.225 g
Water for Injection	Q.S.
Equivalent to 800 KJ (approx. (190)kcal)/L
Na+	38.5 mmol/L
Cl-	38.5 mmol/L
pH	3.5 - 6.5
Theor. Osmolarity	354 mOsm/L
(For full list of excipients, see section 6.1).

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypertonic solution for Intravenous Administration
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Sodium Chloride 0.225% w/v and Dextrose 5% w/v solution is indicated for:</em></p><p>Treatment of dehydration or hypovolaemia in cases where supply of water, sodium chloride and carbohydrates is required due to restriction of the intake of fluids and electrolytes by normal routes.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The choice of the specific sodium chloride and Dextrose concentration, dosage, volume, rate and duration of administration depends on the age, weight, clinical condition of the patient and concomitant therapy. It should be determined by a physician. For patients with electrolyte and glucose abnormalities and for paediatric patients, consult a physician experienced in intravenous fluid therapy. Rapid correction of hyponatraemia and hypernatraemia is potentially dangerous (risk of serious neurologic complications).</p><p>&nbsp;</p><p><strong>Adults, older patients and adolescents (age 12 years and over):</strong></p><p>The recommended dosage is 500 ml to 3 L/24h</p><p><strong><em><u>&nbsp;</u></em></strong></p><p><strong><em><u>Administration rate</u></em></strong></p><p>The infusion rate is usually 40 ml/kg/24h and should not exceed the patient&#39;s glucose oxidation capacities in order to avoid hyperglycaemia. Therefore the maximum acute administration rate is 5 mg/kg/min.</p><p>&nbsp;</p><p><strong>Paediatric population</strong></p><p><em>The dosage varies with weight:</em></p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&middot;&nbsp;&nbsp;&nbsp; 0-10 kg body weight:</p></td><td style="vertical-align:top"><p>100 ml/kg/24h</p></td></tr><tr><td style="vertical-align:top"><p>&middot;&nbsp;&nbsp;&nbsp; 10-20 kg body weight:</p></td><td style="vertical-align:top"><p>1000 ml + (50 ml/kg over 10 kg)/24h</p></td></tr><tr><td style="vertical-align:top"><p>&middot;&nbsp;&nbsp;&nbsp; &gt; 20 kg body weight:</p></td><td style="vertical-align:top"><p>1500 ml + (20 ml/kg over 20 kg)/24h</p></td></tr></tbody></table><p><em>The administration rate varies with weight:</em></p><p><u>&nbsp;</u></p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&middot;&nbsp;&nbsp;&nbsp; 0-10 kg body weight:</p></td><td style="vertical-align:top"><p>6-8 ml/kg/h</p></td></tr><tr><td style="vertical-align:top"><p>&middot;&nbsp;&nbsp;&nbsp; 10-20 kg body weight:</p></td><td style="vertical-align:top"><p>4-6 ml/kg/h</p></td></tr><tr><td style="vertical-align:top"><p>&middot;&nbsp;&nbsp;&nbsp; &gt; 20 kg body weight:</p></td><td style="vertical-align:top"><p>2-4 ml/kg/h</p></td></tr></tbody></table><p><u>&nbsp;</u></p><p>The infusion rate should not exceed the patient&#39;s glucose oxidation capacities in order to avoid hyperglycaemia. Therefore the maximum acute administration rate is 10-18 mg/kg/min, depending on the total body mass.</p><p>For all patients, a gradual increase of flow rate should be considered when starting administration of glucose containing products.</p><p>&nbsp;</p><p><strong><em><u>Method of Administration</u></em></strong></p><p>The administration is performed by intravenous infusion.</p><p>Sodium Chloride 0.225% w/v and Dextrose 5% w/v solution is hypotonic and hyperosmolar, due to the Dextrose content. It has an approximate osmolarity of 354 mOsm/l.</p><p><u>&nbsp;</u></p><p><strong><em><u>Precautions to be taken before manipulating or administering the product</u></em></strong></p><p>Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration. Do not administer unless the solution is clear and the seal is intact. Administer immediately following the insertion of infusion set.</p><p>The solution should be administered with sterile equipment using an aseptic technique.</p><p>The equipment should be primed with the solution in order to prevent air entering the system. Do not use plastic containers in series connections. Such use could result in air embolism due to residual air being drawn from the primary container before the administration of the fluid from the secondary container is completed.</p><p>Pressurizing intravenous solutions contained in flexible plastic containers to increase flow rates can result in air embolism if the residual air in the container is not fully evacuated prior to administration. Use of a vented intravenous administration set with the vent in the open position could result in air embolism. Vented intravenous administration sets with the vent in the open position should not be used with flexible plastic containers.</p><p>Additives may be introduced before or during infusion through the resealable medication port. When additive is used, verify tonicity prior to parenteral administration. Hyperosmolar solutions may cause venous irritation and phlebitis. Thus, any hyperosmolar solution is recommended to be administered through a large central vein, for rapid dilution of the hyperosmotic solution.</p><p>For further information on the product with additives, please see sections 6.2, 6.3 and 6.6.</p><p><u>&nbsp;</u></p><p><strong><em><u>Monitoring</u></em></strong></p><p>Fluid balance and the concentrations of glucose and electrolytes (especially sodium) in plasma must be monitored during administration. Electrolyte supplementation may be indicated according to the clinical needs of the patient.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The solution is contraindicated in patients presenting with:
•	Known hypersensitivity to the product
•	Extracellular hyperhydration or hypervolaemia
•	Fluid and sodium retention
•	Severe renal insufficiency (with oliguria/anuria)
•	Uncompensated cardiac failure
•	Hyponatraemia or hypochloraemia
•	General oedema and ascitic cirrhosis
Clinically significant hyperglycaemia. The solution is also contraindicated in case of uncompensated diabetes, other known glucose intolerances (such as metabolic stress situations), hyperosmolar coma or hyperlactataemia.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Dextrose intravenous infusions are usually isotonic solutions. In the body, however, Dextrose containing fluids can become extremely physiologically hypotonic due to rapid glucose metabolization (see section 4.2).</p><p>Depending on the tonicity of the solution, the volume and rate of infusion and depending on a patient&#39;s underlying clinical condition and capability to metabolize glucose, intravenous administration of glucose can cause electrolyte disturbances most importantly hypo- or hyperosmotic hyponatraemia.</p><p><em>Hyponatraemia:</em></p><p>The infusion of solutions with sodium concentrations &lt;0.9% may result in hyponatraemia. Close clinical monitoring may be warranted.</p><p>Patients with non-osmotic vasopressin release (e.g. in acute illness, pain, post-operative stress, infections, burns, and CNS diseases), patients with heart-, liver- and kidney diseases and patients exposed to vasopressin agonists (see section 4.5) are at particular risk of acute hyponatraemia upon infusion of hypotonic fluids.</p><p>Acute hyponatraemia can lead to acute hyponatraemic encephalopathy (brain oedema) characterized by headache, nausea, seizures, lethargy and vomiting. Patients with brain oedema are at particular risk of severe, irreversible and life-threatening brain injury.</p><p>Children, women in the fertile age and patients with reduced cerebral compliance (e.g. meningitis, intracranial bleeding, and cerebral contusion) are at particular risk of the severe and life-threatening brain swelling caused by acute hyponatraemia</p><p><em>Sodium retention, fluid overload and oedema</em></p><p>Sodium Chloride 0.225 % w/v and Dextrose 5.0 % w/v solution should be used with particular caution, in:</p><p>&bull; Patients with conditions that may cause sodium retention, fluid overload and oedema (central and peripheral), such as</p><p>o Primary hyperaldosteronism,</p><p>o Secondary hyperaldosteronism associated with, for example,</p><p>▪ hypertension,</p><p>▪ congestive heart failure,</p><p>▪ liver disease (including cirrhosis),</p><p>▪ renal disease (including renal artery stenosis, nephrosclerosis)</p><p>o Pre-eclampsia.</p><p>&bull; Patients taking medications that may increase the risk of sodium and fluid retention, such as corticosteroids</p><p><em>Hypokalaemia</em></p><p>The infusion of Sodium Chloride 0.225 % w/v and Dextrose 5.0 % w/v solution may result in hypokalaemia. This medicine should be used with particular caution in patients with or at risk for hypokalemia. Close clinical monitoring may be warranted in, for example:</p><p>&bull; persons with metabolic alkalosis</p><p>&bull; persons with thyrotoxic periodic paralysis, administration of intravenous glucose has been associated in aggravating hypokalaemia</p><p>&bull; persons with increased gastrointestinal losses (e.g., diarrhea, vomiting)</p><p>&bull; prolonged low potassium diet</p><p>&bull; persons with primary hyperaldosteronism</p><p>&bull; patients treated with medications that increase the risk of hypokalaemia (e.g. diuretics, beta-2 agonist, or insulin)</p><p><em>Hypo- and hyperosmolality, serum electrolytes and water imbalance</em></p><p>Depending on the volume and rate of infusion and depending on a patient&#39;s underlying clinical condition and capability to metabolize glucose, intravenous administration of Sodium Chloride 0.225 % w/v and Dextrose 5.0 % w/v solution can cause:</p><p>&bull; Hypo-osmolality</p><p>&bull; Hyperosmolality, osmotic diuresis and dehydration</p><p>&bull; Electrolyte disturbances such as</p><p>o hyponatraemia (see above),</p><p>o hypokalaemia (see above),</p><p>o hypophosphataemia,</p><p>o hypomagnesaemia,</p><p>&bull; Overhydration/hypervolaemia and, for example, congested states, including central (e.g., pulmonary congestion) and peripheral oedema.</p><p>Clinical evaluation and periodic laboratory determinations may be necessary to monitor changes in fluid balance, electrolyte concentrations and acid-base balance during prolonged parenteral therapy or whenever the condition of the patient or the rate of administration warrants such evaluation.</p><p><em>Hyperglycaemia</em></p><p>Rapid administration of glucose solutions may produce substantial hyperglycaemia and a hyperosmolar syndrome. In order to avoid hyperglycaemia the infusion rate should not exceed the patient&#39;s ability to utilize glucose.</p><p>To reduce the risk of hyperglycaemia-associated complications, the infusion rate must be adjusted and/or insulin administered if blood glucose levels exceed levels considered acceptable for the individual patient.</p><p>Intravenous glucose should be administered with caution in patients with, for example:</p><p>&bull; impaired glucose tolerance (such as in diabetes mellitus, renal impairment, or in the presence of sepsis, trauma or shock),</p><p>&bull; severe malnutrition (risk of precipitating a refeeding syndrome, see below),</p><p>&bull; thiamine deficiency, e.g., in patients with chronic alcoholism (risk of severe lactic</p><p>acidosis due to impaired oxidative metabolism of pyruvate),</p><p>&bull; water and electrolyte disturbances that could be aggravated by increased glucose and/or free water load</p><p>Other groups of patients in whom Sodium Chloride 0.225 % w/v and Dextrose 5.0 % w/v solution should be used with caution include:</p><p>&bull; patients with ischemic stroke. Hyperglycaemia has been implicated in increasing cerebral ischemic brain damage and impairing recovery after acute ischemic strokes.</p><p>&bull; patients with severe traumatic brain injury (in particular during the first 24 hours following the trauma). Early hyperglycaemia has been associated with poor outcomes in patients with severe traumatic brain injury.</p><p>&bull; Newborns (see Paediatric glycaemia-related issues).</p><p>Prolonged intravenous administration of glucose and associated hyperglycaemia may result in decreased rates of glucose-stimulated insulin secretion.</p><p><em>Hypersensitivity Reactions</em></p><p>&bull; Hypersensitivity/infusion reactions, including anaphylaxis, have been reported (see section 4.8).</p><p>&bull; Stop the infusion immediately if signs or symptoms of hypersensitivity/infusion reactions develop. Appropriate therapeutic countermeasures must be instituted as clinically indicated.</p><p>Solutions containing glucose should be used with caution in patients with known allergy to corn or corn products</p><p><em>Refeeding syndrome</em></p><p>Refeeding severely undernourished patients may result in the refeeding syndrome that is characterized by the shift of potassium, phosphorus and magnesium intracellularly as the patient becomes anabolic. Thiamine deficiency and fluid retention may also develop. Careful monitoring and slowly increasing nutrient intake while avoiding overfeeding can prevent these complications.</p><p><em>Severe renal impairment</em></p><p>Sodium Chloride 0.225 % w/v and Dextrose 5.0 % w/v solution should be administered with particular caution to patients at risk of (severe) renal impairment. In such patients, administration may result in sodium retention and/or fluid overload.</p><p><em>Paediatric use</em></p><p>The infusion rate and volume depends on the age, weight, clinical and metabolic conditions of the patient, concomitant therapy, and should be determined by a physician experienced in paediatric intravenous fluid therapy.</p><p><u>Paediatric glycaemia-related issues</u></p><p>&bull; Newborns, especially those born premature and with low birth weight, are at increased risk of developing hypo- or hyperglycaemia. Close monitoring during treatment with intravenous glucose solutions is needed to ensure adequate glycaemic control, in order to avoid potential long term adverse effects.</p><p>&bull; Hypoglycaemia in the newborn can cause, e.g.,</p><p>o prolonged seizures,</p><p>o coma and</p><p>o cerebral injury.</p><p>&bull; Hyperglycaemia has been associated with</p><p>o cerebral injury, including intraventricular haemorrhage,</p><p>o late onset bacterial and fungal infection,</p><p>o retinopathy of prematurity,</p><p>o necrotizing enterocolitis,</p><p>o increased oxygen requirements,</p><p>o prolonged length of hospital stay and</p><p>o death.</p><p><u>Paediatric hyponatraemia-related issues</u></p><p>&bull; Children (including neonates and older children) are at increased risk of developing hyponatraemia as well as for developing hyponatraemic encephalopathy.</p><p>&bull; The infusion of hypotonic fluids together with the non-osmotic secretion of ADH may result in hyponatraemia.</p><p>&bull; Hyponatraemia can lead to headache, nausea, seizures, lethargy, coma, cerebral edema and death; therefore, acute symptomatic hyponatraemic encephalopathy is considered a medical emergency.</p><p>&bull; Plasma electrolyte concentrations should be closely monitored in the paediatric population.</p><p>&bull; Rapid correction of hyponatraemia is potentially dangerous (risk of serious neurologic complications). Dosage, rate, and duration of administration should be determined by a physician experienced in paediatric intravenous fluid therapy.</p><p><em>Blood</em></p><p>Sodium Chloride 0.225 % w/v and Dextrose 5.0 % w/v solution should not be administered simultaneously with blood through the same administration set because of the possibility of pseudoagglutination or haemolysis.</p><p><em>Geriatric use</em></p><p>When selecting the type of infusion and the volume/rate of infusion for a geriatric patient, consider that geriatric patients are generally more likely to have cardiac, renal, hepatic, and other diseases or concomitant drug therapy.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Both the glycaemic and effects on water and electrolyte balance should be taken into account when administering Sodium Chloride 0.225 % w/v and Dextrose 5.0 % w/v solution to patients treated with other substances that affect glycaemic control or fluid and/or electrolyte balance.</p><p><em>Drugs leading to an increased vasopressin effect</em></p><p>The below listed drugs increase the vasopressin effect, leading to reduced renal electrolyte free water excretion and increase the risk of hospital acquired hyponatraemia following inappropriately balanced treatment with i.v. fluids (see sections 4.2, 4.4 and 4.8).</p><p>&bull; Drugs stimulating vasopressin release, e.g.: Chlorpropamide, clofibrate, carbamazepine, vincristine, selective serotonin reuptake inhibitors, 3.4-methylenedioxy-N-methamphetamine, ifosfamide, antipsychotics, narcotics</p><p>&bull; Drugs potentiating vasopressin action, e.g.: Chlorpropamide, NSAIDs, cyclophosphamide</p><p>&bull; Vasopressin analogues, e.g.: Desmopressin, oxytocin, terlipressin</p><p>Other medicinal products increasing the risk of hyponatraemia also include diuretics in general and antiepileptics such as oxcarbazepine.</p><p>Caution is advised in patients treated with</p><p>&bull; lithium. Renal sodium and lithium clearance may be increased during administration and can result in decreased lithium levels.</p><p>&bull; corticosteroids, which are associated with the retention of sodium and water (with oedema and hypertension).</p><p>&bull; diuretics, beta-2 agonist, or insulin, whom increase the risk of hypokalemia</p><p>&bull; certain antiepileptic and psychotropic medications that increase the risk of hyponatraemia</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Pregnancy</em></p><p>Intrapartum maternal intravenous glucose infusion may result in foetal hyperglycaemia and metabolic acidosis as well as rebound neonatal hypoglycaemia due to foetal insulin production.</p><p>Sodium Chloride 0.225 % w/v and Dextrose 5.0 % w/v solution should be administrated with special caution for pregnant women during labour particularly if administered in combination with oxytocin due to the risk of hyponatraemia (see sections 4.4, 4.5 and 4.8).</p><p><em>Fertility</em></p><p>There is no information on the effects of Sodium Chloride 0.225 % w/v and Dextrose 5.0 % w/v solution on fertility</p><p><em>Lactation</em></p><p>Sodium Chloride 0.225 % w/v and Dextrose 5.0 % w/v solution can be used during breast-feeding. The potential risks and benefits for each specific patient should be carefully considered before administration.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There is no information on the effects of Sodium Chloride 0.225% w/v and Dextrose 5% w/v solution on the ability to operate an automobile or other heavy machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following adverse reactions have been reported in post-marketing experience, listed by MedDRA System Organ Class (SOC), then where feasible, by Preferred Term in order of severity.</p><p>Frequencies cannot be estimated from the available data as all listed adverse reactions are based on spontaneous reporting</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Class</strong></p></td><td style="vertical-align:top"><p><strong>Adverse reactions</strong></p><p><strong>(Preferred terms)</strong></p></td><td style="vertical-align:top"><p><strong>Frequency</strong></p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><em>Immune system disorders</em></p></td><td style="vertical-align:top"><p>anaphylactic reaction,</p></td><td rowspan="2" style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>hypersensitivity</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><em>Metabolism and nutrition disorders</em></p></td><td style="vertical-align:top"><p>Hyponatraemia,</p></td><td rowspan="2" style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>hyperglycaemia</p></td></tr><tr><td style="vertical-align:top"><p><em>Vascular disorders</em></p></td><td style="vertical-align:top"><p>phlebitis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><em>Skin and subcutaneous tissue disorders</em></p></td><td style="vertical-align:top"><p>rash</p></td><td rowspan="2" style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>pruritus</p></td></tr><tr><td rowspan="5" style="vertical-align:top"><p><em>General disorders and administration site conditions</em></p></td><td style="vertical-align:top"><p>Injection site reactions including:</p></td><td rowspan="5" style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>pyrexia</p></td></tr><tr><td style="vertical-align:top"><p>chills</p></td></tr><tr><td style="vertical-align:top"><p>infusion site pain</p></td></tr><tr><td style="vertical-align:top"><p>infusion site vesicles</p></td></tr></tbody></table><p>&nbsp;</p><p>*Potential manifestation in patients with allergy to corn, see section 4.4</p><p>Adverse reactions may be associated to the medicinal product(s) added to the solution; the nature of the additive will determine the likelihood of any other adverse reactions.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>Adverse Drug Reaction (ADR) Reporting </strong></p><p>&middot;&nbsp;&nbsp; <u>Saudi Arabia:</u></p><p><strong><em>&nbsp;</em></strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td><p><strong><u>The National Pharmacovigilance and Drug Safety Centre (NPC)</u></strong></p><p>&sect; <em>Fa</em><em>x</em><em>: </em>+966-11-205-7662</p><p>&sect; <em>Call NPC at:</em> +966-11-2038222, Ext.: 2317-2356-2353-2354-2334-2340.</p><p>&sect; <em>Toll free phone: </em>8002490000</p><p>&sect; <em>E-mail:</em>npc.drug@sfda.gov.sa</p><p>&sect; <em>W</em><em>e</em><em>bsite: www.sfda.gov.sa/npc</em></p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Excess administration of Sodium Chloride 0.225% w/v and Dextrose 5% w/v solution can cause:</em></p><p>&middot;&nbsp;&nbsp; Hyperglycaemia, adverse effects on water and electrolyte balance, and corresponding complications. For example, severe hyperglycaemia and severe dilutional hyponatraemia, and their complications, can be fatal.</p><p>&middot;&nbsp;&nbsp; Hyponatraemia (which can lead to CNS manifestations, including seizures, coma, cerebral oedema and death).</p><p>&middot;&nbsp;&nbsp; Fluid overload (which can lead to central and/or peripheral oedema).</p><p>&middot;&nbsp;&nbsp; See also sections 4.4 and 4.8</p><p>When assessing an overdose, any additives in the solution must also be considered.</p><p>Clinically significant overdose of Sodium Chloride 0.225% w/v and Dextrose 5% w/v solution may therefore, constitute a medical emergency.</p><p>Interventions include discontinuation of administration, dose reduction, administration of insulin and other measures as indicated for the specific clinical constellation.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Pharmacotherapeutic group:</em> &ldquo;Electrolytes with Carbohydrates&rdquo;,</p><p><em>ATC code:</em> &ldquo;B05BB02&rdquo;.</p><p>Sodium Chloride 0.225% w/v and Dextrose 5% w/v is a hypotonic and hyperosmolar solution of sodium chloride and glucose.</p><p>The pharmacodynamic properties of Sodium Chloride 0.225% w/v and Dextrose 5% w/v solution are those of its components (sodium chloride and glucose).</p><p>Ions, such as sodium, circulate through the cell membrane, using various mechanisms of transport, among which is the sodium pump (Na<sup>+</sup>/K<sup>+</sup>-ATPase). Sodium plays an important role in neurotransmission and cardiac electrophysiology, and also in its renal metabolism.</p><p>Chloride is mainly an extracellular anion. Intracellular chloride is in high concentration in red blood cells and gastric mucosa. Re-absorption of chloride follows re-absorption of sodium.</p><p>Glucose is the principal source of energy in cellular metabolism. The glucose in this solution provides a caloric intake of 200kcal/l.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The pharmacokinetic properties of this solution are those of its components (sodium, chloride and glucose).</p><p>After injection of radiosodium (<sup>24</sup>Na), the half-life is 11 to 13 days for 99% of the injected Na and one year for the remaining 1%. The distribution varies according to tissues: it is fast in muscles, liver, kidney, cartilage and skin; it is slow in erythrocytes and neurones; it is very slow in the bone. Sodium is predominantly excreted by the kidneys, but (as described earlier) there is extensive renal re-absorption. Small amounts of sodium are lost in the faeces and sweat.</p><p>The two main metabolic pathways of glucose are gluconeogenesis (energy storage) and glycogenolysis (energy release). Glucose metabolism is regulated by insulin.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Preclinical safety data of this solution for infusion in animals are not relevant since its constituents are physiological components of animal and human plasma.</p><p>Toxic effects are not to be expected under the condition of clinical application.</p><p>The safety of potential additives should be considered separately.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><em>The excipients in each 100 ml are:</em></strong></p><p>Water for Injection&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;.Q.S. to 100 ml</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Incompatibility of the medicinal product to be added with the solution in the Viaflo container must be assessed before addition. In the absence of compatibility studies, this solution must not be mixed with other medicinal products.</p><p>The instructions for use of the medicinal product to be added must be consulted.</p><p>Before adding a drug, verify it is soluble and stable in water at the pH of Sodium Chloride 0.225% w/v and Dextrose 5.0% w/v solution (see section 3).</p><p>As guidance, the following medications are incompatible with the Sodium Chloride 0.225 % w/v &amp; Dextrose 5.0% w/v solution (non-exhaustive listing):</p><p>- Ampicillin sodium</p><p>- Mitomycin</p><p>- Erythromycin lactobionate</p><p>- Human insulin</p><p>Those additives known to be incompatible should not be used.</p><p>Because of the presence of Dextrose, Sodium chloride 0.225% w/v and Dextrose 5.0% w/v solution should not be administered simultaneously with blood through the same administration set because of the possibility of pseudoagglutination or haemolysis.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Unopened:
5 years from the manufacturing date. The expiry date refers to the last day of the month.

It is recommended that the product is used immediately once opened (see section 4.2).
From a microbiological point of view, solutions containing additives should be used immediately. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&sect; Keep in a safe place, out of the reach and sight of children.</p><p>&sect; Store below 25&deg; C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Bottle size:</em> 500 ml &times; 10 bottles</p><p>Sterile, pyrogen free</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Discard after single use.</p><p>Discard any unused portion.</p><p>Do not reconnect partially used bottles.</p><p>For method of administration and precautions to be taken before handling or administering the medicinal product, please see also section 4.2.</p><p><u>1. Opening</u></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Check for minute leaks. If leaks are found, discard solution, as sterility may be impaired.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Check the solution for limpidity and absence of foreign matters. If solution is not clear or contains foreign matters, discard the solution.</p><p><u>2. Preparation for administration</u></p><p>Use sterile material for preparation and administration.</p><p>a. Suspend container from eyelet support.</p><p>b. Remove plastic protector from outlet port at bottom of container:</p><p>c. Use an aseptic method to set up the infusion</p><p>d. Attach administration set. Refer to complete directions accompanying set for connection, priming of the set and administration of the solution.</p><p><u>3. Techniques for injection of additive medications</u></p><p>Warning: Additives may be incompatible.</p><p>To add medication before administration</p><p>a. Disinfect medication site.</p><p>b. Using syringe with 19 to 22 gauge needle, puncture resealable medication port and inject.</p><p>c. Mix solution and medication thoroughly. For high-density medication such as potassium chloride, tap the ports gently while ports are upright and mix.</p><p><strong><em>Caution: Do not store bottles containing added medications. See section 6.3.</em></strong></p><p>To add medicationduring administration</p><p>a. Close clamp on the set.</p><p>b. Disinfect medication site.</p><p>c. Using syringe with 19 to 22-gauge needle, puncture resealable medication port and inject.</p><p>d. Remove container from IV pole and/or turn to an upright position.</p><p>e. Evacuate both ports by tapping gently while the container is in an upright position.</p><p>f. Mix solution and medication thoroughly.</p><p>g. Return container to in use position, re-open the clamp and continue administration.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Kuwait Saudi Pharmaceutical Industries Company
Tel: +965 24745012/3/4
Fax: +965 24745361, P. O. Box: 5512, postal code: 13056 Safat, Kuwait
Website: www.kspico.com

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                April 2020
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>